Gemmer Asset Management LLC Neogenomics Inc Transaction History

Gemmer Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$7.06 - $13.97 $381 - $754	-54 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$12.15 - $35.28 $1,360 - $3,951	-112 Reduced 67.47%	54 $0
Q1 2020 May 01, 2020	BUY	$20.5 - $34.53 $1,619 - $2,727	79 Added 90.8%	166 $4,000
Q4 2019 Jan 17, 2020	SELL	$18.96 - $29.84 $1,004 - $1,581	-53 Reduced 37.86%	87 $3,000
Q3 2019 Oct 11, 2019	BUY	$19.12 - $26.24 $1,854 - $2,545	97 Added 225.58%	140 $3,000
Q2 2019 Jul 18, 2019	BUY	$19.57 - $24.1 $841 - $1,036	43 New	43 $1,000

278

127M

581K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.